Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Androgen Independent Prostate Cancer

PSA Drop Seen with New Prostate Cancer Drug

Half of a group of men with castration-resistant prostate cancer (CRPC) had biochemical responses to treatment with an investigational androgen receptor modulator, data from a preliminary clinical study showed.

During 12 weeks of treatment with galeterone, prostate-specific antigen (PSA) declined by at least 30% in 24 of 49 patients, 11 of whom had declines… PSA Drop Seen with New Prostate Cancer Drug   



brachytherapy2 - mortality1 - plos one1 - urethral diverticulum1 - prostate adenocarcinoma1 - breast cancer3 - phytotherapy1 - obese kidney transplant recipients1 - vitamin supplements1 - anal sphincter1 - monosomy1 - vigorous activity1 - av fistula1 - bacteriuria2 - predialysis1 - matrix component3 - disease-related anemia1 - crescenteric glomerulonephritis1 - polycystic kidney and hepatic disease type i1 - bladder calculi1 - cinacalcet1 - food and drug administration1 - urgency incontinence2 - crura1 - journal of clinical oncology1 - lower kidney function2 - kidney disorder1 - scientific registry of transplant recipients1 - nephrosis1 - prostate tissue cells1 -